Zobrazeno 1 - 10
of 123
pro vyhledávání: '"S M, Lichtman"'
Autor:
S M Lichtman, Arti Hurria
Publikováno v:
British Journal of Cancer
This abbreviated review outlines the physiologic changes associated with aging, and examines how these changes may affect the pharmacokinetics and pharmacodynamics of anticancer therapies. We also provide an overview of studies that have been conduct
Autor:
W A Nahhas, Paul S. Ritch, S R Weisberg, S Yanovich, S M Lichtman, David R. Gandara, P Braly, M D Adelson, E S Podczaski, Howard D. Homesley
Publikováno v:
Journal of Clinical Oncology. 13:490-496
PURPOSE Diethyldithiocarbamate (DDTC) blocks cisplatin-induced toxicities in animal models without inhibiting antitumor effects. DDTC chemoprotection was tested in a randomized, multicenter, double-blind comparison versus placebo (PB) in patients wit
Autor:
S M, Lichtman
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 33(1)
Bacterial translocation is a phenomenon in which live bacteria cross the intestinal barrier. The definition may be broadened to include transmural passage of bacterial cell wall components such as lipopolysaccharide and peptidoglycan polysaccharide.
Publikováno v:
American journal of hematology. 66(3)
Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.
Autor:
S M, Lichtman, J A, Skirvin
Publikováno v:
Oncology (Williston Park, N.Y.). 14(12)
The fastest growing segment of the US population is the group over the age of 65 years. In the next 30 years, this group will comprise over 20% of the population. Because 60% of all cancers occur in this age group, there will be an expected rise in t
Autor:
S M, Lichtman, D, Niedzwiecki, M, Barcos, T L, Carlisle, M R, Cooper, J L, Johnson, B A, Peterson
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11(9)
Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have suggested infusional therapy may be beneficial.This trial used an infusional regimen called I-CHOPE in resistant patients who had previousl
Publikováno v:
American journal of hematology. 61(4)
The increased cure rate of hematologic malignancies including the use of bone marrow transplantation has focused attention on the chronic toxicity and quality of life of the survivors. We have observed five patients who have been diagnosed with clini
Autor:
S M, Lichtman, R L, Bayer
Publikováno v:
Clinics in geriatric medicine. 13(2)
Tumors in the gastrointestinal system are a significant health problem for older adults. If diagnosed at an early stage, many patients are curable. At advanced stages, however, only palliative therapy can be offered. Adjuvant therapy is beneficial on
Autor:
D, Serrano, J, Monteiro, S L, Allen, J, Kolitz, P, Schulman, S M, Lichtman, A, Buchbinder, V P, Vinciguerra, N, Chiorazzi, P K, Gregersen
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(3)
The role of T cells in chronic lymphocytic leukemia (CLL) has not been extensively investigated, since the most prominent cellular abnormality in CLL involves the clonal expansion of B cells. In this study we have undertaken a comprehensive analysis
Publikováno v:
Oncogene. 8(12)
We performed cloning and sequence analysis of translocation junctions at 11q- and 22q- (Ph1) chromosomes and the corresponding germline DNAs of a variant Ph1-positive CML with t(9;22;11)(q34;q11;q13). Southern blot analysis using probes for different